van Straten Michael, Bardenstein Svetlana, Keningswald Gaby, Banai Menachem
"Hachaklait", Mutual Society for Veterinary Services, P.O.B. 3039, Caesarea Industrial Park, 38900, Israel.
Kimron Veterinary Institute, P.O.B. 12, Bet Dagan 502501, Israel.
Vaccine. 2016 Nov 21;34(48):5837-5839. doi: 10.1016/j.vaccine.2016.10.011. Epub 2016 Oct 19.
Brucellosis is a zoonotic disease that can cause severe illness in humans and considerable economic loss in the livestock industry. Although small ruminants are the preferential host for Brucella melitensis, this pathogen has emerged as a cause for Brucella outbreaks in cattle. S19 vaccination is implemented in many countries where B. abortus is endemic but its effectiveness against B. melitensis has not been validated. Here we show that vaccine effectiveness in preventing disease transmission between vaccinated and unvaccinated cohorts, as determined by seroconversion, was 87.2% (95% CI 69.5-94.6%). Furthermore, vaccination was associated with a reduced risk for abortion. Together, our data emphasize the role S19 vaccination could play in preventing B. melitensis outbreaks in areas where this pathogen is prevalent in small ruminant populations.
布鲁氏菌病是一种人畜共患病,可导致人类严重疾病,并给畜牧业造成巨大经济损失。尽管小型反刍动物是羊种布鲁氏菌的主要宿主,但这种病原体已成为牛群中布鲁氏菌病暴发的一个原因。在许多牛种布鲁氏菌流行的国家实施了S19疫苗接种,但其对羊种布鲁氏菌的有效性尚未得到验证。在此我们表明,通过血清转化确定,疫苗在预防接种和未接种群体之间疾病传播方面的有效性为87.2%(95%置信区间69.5-94.6%)。此外,接种疫苗与流产风险降低有关。总之,我们的数据强调了S19疫苗接种在预防羊种布鲁氏菌在小型反刍动物群体中流行的地区暴发方面可能发挥的作用。